Table 3.

KEGG Pathway Enrichment of differentially expressed genes in 10 d plants (Benjamini corrected p < 0.05).

Treatments		Differentially expressed genes	Pathways	Genes mapped to each pathway	Benjamini
Root	50 kPa	112; e.g., AT4G26010, AT4G10270, AT4G33560, AT5G24670,	N/A	N/A	N/A
	50 kPa/NormOx	25; e.g., AT4G14630, AT1G78860, AT3G23190, AT5G47450,	N/A	N/A	N/A
Shoot	50 kPa	23; e.g., AT1G02930, AT2G24850, AT1G02850, AT4G35180,	N/A	N/A	N/A
	50 kPa/NormOx	2: AT5G18600, AT1G23130,	N/A	N/A	N/A
Root	25 kPa	256; e.g., AT5G15120, AT4G25110, AT3G58810, AT2G20630,	Metabolic pathways	39 (15.4%)	7.90E-04
	25 kPa/NormOx	17; e.g., AT2G07671, AT1G72440, AT5G03440, AT3G02550,	N/A	N/A	N/A
	97 kPa/HypOx	167; e.g., AT5G54960, AT1G77120,	Glycolysis/Gluconeogenesis	9 (5.4%)	2.20E-04
		AT1G17290, AT1G72360,	Metabolic pathways	32 (19.3%)	1.50E-04
			Biosynthesis of secondary metabolites	21 (12.7%)	4.30E-03
Shoot	25 kPa	55; e.g., AT3G25760, AT5G42650, AT4G15440, AT3G45140,	alpha-Linolenic acid metabolism	4 (7.3%)	9.40E-03
	25 kPa/NormOx	1: AT5G67300	N/A	N/A	N/A
	97 kPa/HypOx	31; e.g., AT1G75280, AT2G39310,	Metabolic pathways	12 (38.7%)	8.50E-03
		AT5G48880, AT2G31390,	Cysteine and methionine metabolism	4 (12.9%)	1.70E-02
			Biosynthesis of secondary metabolites	9 (29%)	2.00E-02
			alpha-Linolenic acid metabolism	3 (9.7%)	2.70E-02